Dr. Paul A. DiSilvestro
Claim this profileWomen and Infants Hospital
Area of expertise
Ovarian Cancer
Paul A. DiSilvestro has run 4 trials for Ovarian Cancer. Some of their research focus areas include:
Fallopian Tube Cancer
Paul A. DiSilvestro has run 3 trials for Fallopian Tube Cancer. Some of their research focus areas include:
Affiliated Hospitals
Women And Infants Hospital
Clinical Trials Paul A. DiSilvestro is currently running
Iohexol-aided Carboplatin Dosing
for Cancer
This trial studies how well iohexol helps doctors calculate the dose of carboplatin for cancer patients. By measuring kidney function more accurately, doctors can improve the effectiveness and safety of carboplatin treatment. Carboplatin is a platinum-based chemotherapy drug used to treat various cancers, known for its improved toxicity profile compared to cisplatin.
Recruiting
1 award
Phase 1
7 criteria
Targeted Therapy
for Solid Tumors
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting
1 award
Phase 2
17 criteria
More about Paul A. DiSilvestro
Clinical Trial Related
2 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Paul A. DiSilvestro has experience with
- Cisplatin
- Biospecimen Collection
- Olaparib
- Paclitaxel
- Ipatasertib
- Behavioral Dietary Intervention
Breakdown of trials Paul A. DiSilvestro has run
Ovarian Cancer
Fallopian Tube Cancer
Ovarian Adenocarcinoma
Ovarian Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul A. DiSilvestro specialize in?
Paul A. DiSilvestro focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is Paul A. DiSilvestro currently recruiting for clinical trials?
Yes, Paul A. DiSilvestro is currently recruiting for 3 clinical trials in Providence Rhode Island. If you're interested in participating, you should apply.
Are there any treatments that Paul A. DiSilvestro has studied deeply?
Yes, Paul A. DiSilvestro has studied treatments such as Cisplatin, Biospecimen Collection, Olaparib.
What is the best way to schedule an appointment with Paul A. DiSilvestro?
Apply for one of the trials that Paul A. DiSilvestro is conducting.
What is the office address of Paul A. DiSilvestro?
The office of Paul A. DiSilvestro is located at: Women and Infants Hospital, Providence, Rhode Island 02905 United States. This is the address for their practice at the Women and Infants Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.